Investigators from the RePORT-Brazil team attended the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver and made presentations on recent findings and articles.
Poster Presentations:
Dr. Gustavo Amorim, PhD: "Estimating Optimal Anti-TB Drug Concentrations in a Prospective, Observational Cohort in Brazil"
Dr. Felipe Ridolfi, PhD, MD: “Pharmacogenetic Associations With HIV-1 Virologic Suppression Among Patients with TB/HIV in Brazil”
Dr. Maria Arriaga, PhD: "Effect of Smoking on Longitudinal Interferon-ϒ Release Assay Results Among Tuberculosis Contacts"